DIS vs PFE: Which Is the Better Buy?
Side-by-side comparison of The Walt Disney Company and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
The Walt Disney Company · Communication Services
$103.49
+32.3% upside to fair value
Med Conviction
Grade B
High Quality
VS
Pfizer Inc. · Healthcare
$27.64
+12.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
DIS has more upside to fair value
(+32.3%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DIS |
PFE |
| Current Price |
$103.49 |
$27.64 |
| Fair Value Estimate |
$136.94 |
$30.94 |
| Upside to Fair Value |
+32.3%
|
+12.0%
|
| Market Cap |
$179.7B |
$157.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
9.5x
|
17.4x
|
| Price / Sales |
1.8x
|
2.5x
|
| Price / FCF |
21.7x
|
14.3x
|
| Revenue Growth YoY |
+6.8%
|
+2.6%
|
| Gross Margin |
37.6%
|
71.3%
|
| Operating Margin |
16.0%
|
25.1%
|
| Return on Equity |
7.9%
|
4.9%
|
| Dividend Yield |
1.45% |
6.22% |
| FCF Yield |
4.61%
|
6.97%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
The Walt Disney Company operates a global entertainment empire spanning two primary divisions: Disney Media and Entertainment Distribution, which houses the ABC, ESPN, Disney, Freeform, FX, Fox, National Geographic and Star networks along with the Walt Disney Pictures, Twentieth Century Studios, Marvel, Lucasfilm, Pixar and Searchlight Pictures studios and the Disney+, Disney+ Hotstar, ESPN+, Hul…
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating …
Accumulation Zones
| Metric |
DIS |
PFE |
| Zone Low |
$102.70 |
$23.21 |
| Zone High |
$116.40 |
$26.30 |
| In Buy Zone? |
Yes
|
No
|